However, after several years without success, she connected with Ulta’s then-CEO Mary Dillon and senior vice president of ...

By Blaise UdunzeThis piece speaks directly to the current consciousness of many Nigerians as some crises erupt with noise, explosions of violence, economic shocks, political upheavals and then some ...

Postmortem analyses of 3,577 cases in four state capitals reveal a consistent association between psychoactive substances and homicides, accidents, and suicides, with distinct regional patterns. Among ...

Different psychedelics create very similar brain pattern activity, giving scientists new insight into potential mental health ...

Suffolk County's interagency East End Drug Task Force is investigating last week's death of swimsuit designer Martha Nolan-O’Slatarra on a boat docked at the Montauk Yacht Club, a source familiar with ...

Forbes contributors publish independent expert analyses and insights. Amanda Lauren writes about interior design and real estate. As the seasons shift, so do the ways designers think about interiors.

Abstract: Spatiotemporal self-organization is an emergent phenomenon governing cellular behavior across diverse living systems with key implications for biological functionality. Understanding the ...

Despite decades of progress in pharmaceutical R&D, the earliest phase of drug discovery—where molecules are conceived and designed—remains costly, inefficient, and burdened by high failure rates. Most ...

MARION, Ohio — A judge sentenced a Marion man to at least 27 years in prison for his role in what authorities described as a large-scale, multi-state drug trafficking organization. Judge Matthew ...

Control Substance Designer from any MCP-compatible AI client (Claude Code, Claude Desktop, Cursor) — create graphs, build nodes, connect them, set parameters, generate full PBR material graphs from a ...

After sharing word that it would be prioritizing artificial intelligence to aid discovery work, Takeda Pharmaceuticals has inked a multiyear deal to access Iambic Therapeutics' broad suite of drug ...